FRANKFURT--The following is a summary of analysts' forecasts for
Sanofi SA (SNY) first-quarter results, based on a poll of nine
analysts conducted by Dow Jones Newswires (figures in million
euros, EPS, dividend and target price in euro, according to IFRS).
Earnings figures are scheduled to be released April 30.
===
Business Business
Net Sales Oper. net Business
1st Quarter sales Lantus Income income EPS
AVERAGE 8,490 1,612 2,222 1,579 1.20
Prev. Year 7,842 1,448 2,145 1,547 1.17
+/- in % +8.3 +11 +3.6 +2.0 +2.9
MEDIAN 8,474 1,614 2,214 1,567 1.20
Maximum 8,704 1,641 2,396 1,691 1.29
Minimum 8,230 1,572 2,082 1,488 1.14
Amount 9 7 9 9 8
Barclays 8,690 1,605 2,296 1,615 1.23
Bernstein 8,704 1,639 2,396 1,691 1.29
BofA-Merrill Lynch 8,474 1,572 2,153 1,512 1.16
Deutsche Bank 8,409 1,598 2,214 1,565 1.20
Exane BNP Paribas 8,286 1,641 2,082 1,488 1.14
Independent Res. 8,230 -- 2,230 1,600 --
Jefferies 8,666 1,615 2,235 1,611 1.22
Morgan Stanley 8,471 -- 2,191 1,567 1.20
UBS 8,476 1,614 2,201 1,558 1.19
Target price Rating DPS 2015
AVERAGE 99.25 positive 2 AVERAGE 2.92
Prev. Quarter 80.29 neutral 7 Prev. Year 2.85
+/- in % +24 negative 0 +/- in % +2.3
MEDIAN 100.50 MEDIAN 2.95
Maximum 107.00 Maximum 3.05
Minimum 89.00 Minimum 2.63
Amount 8 Amount 6
Barclays 93.00 Equalweight 3.02
Bernstein 107.00 Outperform 2.63
BofA-Merrill Lynch 105.00 Buy 2.90
Deutsche Bank 94.00 Hold 3.00
Exane BNP Paribas 89.00 Neutral --
Independent Res. 105.00 Hold 2.90
Jefferies 101.00 Hold --
Morgan Stanley -- Equalweight --
UBS 100.00 Neutral 3.05
===
Year-earlier figures are as reported by the company.
DJG/err
Subscribe to WSJ: http://online.wsj.com?mod=djnwires